Randy Berholtz, EVP, CORPORATE DEVELOPMENT at INNOVUS PHARMACEUTICALS, INC. (INNV), bought 11,890 shares at $0.10 ($1K) on 2017-11-22, disclosed to the SEC on 2017-11-27.
Open-market purchase of $1k INNV by EVP, CORPORATE DEVELOPMENT. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.10 | 2,000 | $200 | 16.8% |
| 2 | $0.10 | 4,900 | $490 | 41.2% |
| 3 | $0.10 | 4,990 | $499 | 42.0% |
| Total | $0.10 avg | 11,890 | $1K | 100% |